Raydiant Oximetry
"Raydiant's device is promising as a solution to the problem of identifying fetal distress, thereby enabling an improvement over the current standard of care."
Dr. Elizabeth Cherot, MD, MBA, March of Dimes President and CEO
Raydiant Oximetry is a venture-backed, clinical-stage company dedicated to improving outcomes for moms and babies during childbirth. The company was founded by Neil P. Ray, MD, a pediatric anesthesiologist, to find a solution to the pervasive problem of identifying fetal distress and potentially avoiding medically unnecessary Cesarean sections, which can have short- and long-term implications for the mom and child.
Raydiant Oximetry was recently awarded a National Institutes of Health Phase II SBIR grant for “Advancing Fetal Assessment during Labor with Transabdominal Fetal Oximetry” to support its continued development of this important solution. And, The Galien Foundation named Raydiant Oximetry as a 2023 Prix Galien USA Nominee for "Best Startup.” Winners will be announced on October 26.
If you have any questions about our Innovation Fund or would like to learn more about companies like Raydiant, please reach out to Eric Schaefer at [email protected].
Additional information